332 related articles for article (PubMed ID: 17420118)
1. Non-traditional markers of atherosclerosis potentiate the risk of coronary heart disease in patients with type 2 diabetes and metabolic syndrome.
Bianchi C; Penno G; Malloggi L; Barontini R; Corfini M; Giovannitti MG; Di Cianni G; Del Prato S; Miccoli R
Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):31-8. PubMed ID: 17420118
[TBL] [Abstract][Full Text] [Related]
2. Association of serum uric acid and metabolic syndrome in type 2 diabetes.
Bonakdaran S; Kharaqani B
Curr Diabetes Rev; 2014 Mar; 10(2):113-7. PubMed ID: 24588601
[TBL] [Abstract][Full Text] [Related]
3. Discordance of Low-Density Lipoprotein and High-Density Lipoprotein Cholesterol Particle Versus Cholesterol Concentration for the Prediction of Cardiovascular Disease in Patients With Metabolic Syndrome and Diabetes Mellitus (from the Multi-Ethnic Study of Atherosclerosis [MESA]).
Tehrani DM; Zhao Y; Blaha MJ; Mora S; Mackey RH; Michos ED; Budoff MJ; Cromwell W; Otvos JD; Rosenblit PD; Wong ND
Am J Cardiol; 2016 Jun; 117(12):1921-7. PubMed ID: 27156827
[TBL] [Abstract][Full Text] [Related]
4. [Correlation between atherosclerosis--coronary disease and insulin resistance, regarded as the basis of metabolic syndrome].
Mihalcea C; Pandele GI
Rev Med Chir Soc Med Nat Iasi; 2010; 114(1):59-68. PubMed ID: 20509277
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders.
Onat A; Hergenç G; Sansoy V; Fobker M; Ceyhan K; Toprak S; Assmann G
Atherosclerosis; 2003 May; 168(1):81-9. PubMed ID: 12732390
[TBL] [Abstract][Full Text] [Related]
6. Weight, the metabolic syndrome, and coronary heart disease in type 2 diabetes: associations among a national French sample of adults with diabetes-the ENTRED study.
Hillier TA; Fosse S; Balkau B; Simon D; Eschwège E; Fagot-Campagna A
J Cardiometab Syndr; 2006; 1(5):318-25. PubMed ID: 17679788
[TBL] [Abstract][Full Text] [Related]
7. Alirocumab therapy in individuals with type 2 diabetes mellitus and atherosclerotic cardiovascular disease: analysis of the ODYSSEY DM-DYSLIPIDEMIA and DM-INSULIN studies.
Ray KK; Del Prato S; Müller-Wieland D; Cariou B; Colhoun HM; Tinahones FJ; Domenger C; Letierce A; Mandel J; Samuel R; Bujas-Bobanovic M; Leiter LA
Cardiovasc Diabetol; 2019 Nov; 18(1):149. PubMed ID: 31706300
[TBL] [Abstract][Full Text] [Related]
8. Triglyceride/HDL-cholesterol ratio is an independent predictor for coronary heart disease in a population of Iranian men.
Hadaegh F; Khalili D; Ghasemi A; Tohidi M; Sheikholeslami F; Azizi F
Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):401-8. PubMed ID: 19091534
[TBL] [Abstract][Full Text] [Related]
9. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
Nesto RW
Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526
[TBL] [Abstract][Full Text] [Related]
10. LDL-cholesterol versus non-HDL-to-HDL-cholesterol ratio and risk for coronary heart disease in type 2 diabetes.
Eliasson B; Gudbjörnsdottir S; Zethelius B; Eeg-Olofsson K; Cederholm J;
Eur J Prev Cardiol; 2014 Nov; 21(11):1420-8. PubMed ID: 23774274
[TBL] [Abstract][Full Text] [Related]
11. Correlation between the triglyceride-to-high-density lipoprotein cholesterol ratio and other unconventional lipid parameters with the risk of prediabetes and Type 2 diabetes in patients with coronary heart disease: a RCSCD-TCM study in China.
Yang T; Liu Y; Li L; Zheng Y; Wang Y; Su J; Yang R; Luo M; Yu C
Cardiovasc Diabetol; 2022 Jun; 21(1):93. PubMed ID: 35659300
[TBL] [Abstract][Full Text] [Related]
12. log(TG)/HDL-C is related to both residual cardiometabolic risk and β-cell function loss in type 2 diabetes males.
Hermans MP; Ahn SA; Rousseau MF
Cardiovasc Diabetol; 2010 Dec; 9():88. PubMed ID: 21156040
[TBL] [Abstract][Full Text] [Related]
13. Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the FIELD randomised trial.
Scott R; Donoghoe M; Watts GF; O'Brien R; Pardy C; Taskinen MR; Davis TM; Colman PG; Manning P; Fulcher G; Keech AC;
Cardiovasc Diabetol; 2011 Nov; 10():102. PubMed ID: 22104275
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Metabolic Syndrome and Its Associated Risk Factors in Type 2 Diabetes: A Descriptive Cross-Sectional Study at the Komfo Anokye Teaching Hospital, Kumasi, Ghana.
Agyemang-Yeboah F; Eghan BAJ; Annani-Akollor ME; Togbe E; Donkor S; Oppong Afranie B
Biomed Res Int; 2019; 2019():4562904. PubMed ID: 31187045
[No Abstract] [Full Text] [Related]
15. Lack of Associations between Elevated Serum Uric Acid and Components of Metabolic Syndrome Such as Hypertension, Dyslipidemia, and T2DM in Overweight and Obese Chinese Adults.
Li L; Song Q; Yang X
J Diabetes Res; 2019; 2019():3175418. PubMed ID: 31871945
[TBL] [Abstract][Full Text] [Related]
16. LDL/apo B ratio predict coronary heart disease in Type 2 diabetes independent of ASCVD risk score: A case-cohort study.
Rabizadeh S; Rajab A; Mechanick JI; Moosaie F; Rahimi Y; Nakhjavani M; Esteghamati A
Nutr Metab Cardiovasc Dis; 2021 May; 31(5):1477-1485. PubMed ID: 33810957
[TBL] [Abstract][Full Text] [Related]
17. Serum uric acid to HDL-cholesterol ratio is a strong predictor of metabolic syndrome in type 2 diabetes mellitus.
Kocak MZ; Aktas G; Erkus E; Sincer I; Atak B; Duman T
Rev Assoc Med Bras (1992); 2019 Jan; 65(1):9-15. PubMed ID: 30758414
[TBL] [Abstract][Full Text] [Related]
18. High Prevalence of Vitamin D Deficiency and Correlation of Serum Vitamin D with Cardiovascular Risk in Patients with Metabolic Syndrome.
Alkhatatbeh MJ; Abdul-Razzak KK; Khasawneh LQ; Saadeh NA
Metab Syndr Relat Disord; 2017 Jun; 15(5):213-219. PubMed ID: 28346853
[TBL] [Abstract][Full Text] [Related]
19. Testosterone concentrations and risk of cardiovascular events in androgen-deficient men with atherosclerotic cardiovascular disease.
Boden WE; Miller MG; McBride R; Harvey C; Snabes MC; Schmidt J; McGovern ME; Fleg JL; Desvigne-Nickens P; Anderson T; Kashyap M; Probstfield JL
Am Heart J; 2020 Jun; 224():65-76. PubMed ID: 32335402
[TBL] [Abstract][Full Text] [Related]
20. Comparative effects of simvastatin and atorvastatin in hypercholesterolemic patients with characteristics of metabolic syndrome.
Hunninghake DB; Ballantyne CM; Maccubbin DL; Shah AK; Gumbiner B; Mitchel YB
Clin Ther; 2003 Jun; 25(6):1670-86. PubMed ID: 12860491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
